resorcinol has been researched along with Prostatic Neoplasms in 2 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nepali, K | 1 |
Lin, MH | 1 |
Chao, MW | 1 |
Peng, SJ | 1 |
Hsu, KC | 1 |
Eight Lin, T | 1 |
Chen, MC | 1 |
Lai, MJ | 1 |
Pan, SL | 1 |
Liou, JP | 1 |
Nakamura, A | 1 |
Shirai, T | 1 |
Takahashi, S | 1 |
Ogawa, K | 1 |
Hirose, M | 1 |
Ito, N | 1 |
2 other studies available for resorcinol and Prostatic Neoplasms
Article | Year |
---|---|
Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells.
Topics: Amides; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; | 2019 |
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia; | 1991 |